Immune responses and exacerbations in severe asthma.
Immune responses and exacerbations in severe asthma.
复制标题
重症哮喘患者的免疫反应和病情加重。
DOI:
10.1016/j.coi.2021.03.004
复制
发表时间:
2021-10
影响因子:
7
通讯作者:
Ray A
中科院分区:
文献类型:
--
作者:
Camiolo MJ;Kale SL;Oriss TB;Gauthier M;Ray A
Asthma as a clinical entity manifests with a broad spectrum of disease severity. Unlike milder asthma, severe disease is poorly controlled by inhaled corticosteroids, the current standard of care. Transcriptomic data, along with patient characteristics and response to biologics show that though Type 2 (T2) immune response remains an integral feature of asthma, additional molecular and immunologic factors may play important roles in pathogenesis. Mechanisms of T2 development, cellular sources of T2 cytokines and their relationship to additional immune pathways concurrently activated may distinguish several different sub-phenotypes, and perhaps endotypes of asthma, with differential response to non-specific and targeted anti-inflammatory therapies. Recent data have also associated non-T2 cytokines derived from T cells, particularly IFN-γ, and epithelial mediators with severe asthma. These topics and their relationships to acute asthma exacerbations are discussed in this review.
登录
查看更多内容
影响因子:
7.3
作者:
Bosnjak, Berislav;Kazemi, Sahar;Epstein, Michelle M.
通讯作者:
Epstein, Michelle M.
影响因子:
4.3
作者:
Graff, Sophie;Bricmont, Noemie;Schleich, Florence
通讯作者:
Schleich, Florence
影响因子:
158.5
作者:
Castro, M.;Corren, J.;Teper, A.
通讯作者:
Teper, A.
DOI:
10.1164/rccm.201808-1516oc
发表时间:
2019-02-15
影响因子:
24.7
作者:
Bloom, Chloe I.;Palmer, Thomas;Cullinan, Paul
通讯作者:
Cullinan, Paul
DOI:
10.1164/rccm.200307-1004oc
发表时间:
2004-03-01
影响因子:
24.7
作者:
Dorman, SC;Efthimiadis, A;Sehmi, R
通讯作者:
Sehmi, R